Greg Freiherr, Industry Consultant
Greg Freiherr, Industry Consultant

Greg Freiherr has reported on developments in radiology since 1983. He runs the consulting service, The Freiherr Group.

Blog | Greg Freiherr, Industry Consultant | January 30, 2013

Alzheimer’s, ALS and Concussions: Connecting the Dots

In what one day may be recognized as a melding of epidemiology and medical imaging, researchers are associating human conditions once viewed as unavoidable or natural consequences of American life as diseases with commonalities that can be seen and measured in the living brain. It is a transformation I have lived through from the beginning, remembering how my grandmother’s senility was viewed as an inevitable consequence of age; how those rooted in that perception mispronounced Alzheimer’s disease as “old timer’s disease;” how coaches — and parents — joked about high school players getting their “bells rung” in football; and how those impacts are now viewed as concussions.

In September it was reported in the peer reviewed journal Neurology that pro football players may have up to four times higher risk of death from Alzheimer's and Lou Gehrig's disease (ALS). Last week the American Journal of Geriatric Psychiatry published medical images online showing proteins, called tau proteins, often found in elderly patients with Alzheimer’s disease but in this case present in the brains of living NFL players (“Study First to Image Concussion-Related Abnormal Brain Proteins in Retired NFL Players,” http://www.itnonline.com/article/study-first-image-concussion-related-abnormal-brain-proteins-retired-nfl-players). Previous studies had shown that pro athletes in contact sports are at risk of developing chronic traumatic encephalopathy (CTE), a degenerative condition associated with accumulation of tau protein.

Brick by metaphorical brick, researchers are building a road to understanding brain disease and medical imaging is lighting the way. University of California, Los Angeles (UCLA) researchers used a positron emission tomography (PET) biomarker, 18F-FDDNP (2-(1-{6-[(2-[18F]Fluoroethyl)(methyl)amino]-2-naphthyl}ethylidene)malononitrile), which binds to deposits of amyloid plaques and neurofibrillary tau tangles, the hallmarks of Alzheimer’s disease, to look at the brains of NFL players. Compared to healthy control subjects, these athletes had elevated levels of FDDNP in the amygdala and subcortical regions of the brain, regions that control learning, memory, behavior and emotions. Players who had more concussions had higher 18F-FDDNP levels on PET scans.

The connection between football and the risk of death due to neurodegenerative disease came from a study by the National Institute for Occupational Safety and Health (NIOSH) in Cincinnati, published online in Neurology (http://www.neurology.org/content/early/2012/09/05/WNL.0b013e31826daf50.abstract), which looked at 3,439 NFL players. Of the 334 who died, seven had Alzheimer's disease and seven had ALS — four times the rate for the general population.

“While CTE is a separate diagnosis, the symptoms are often similar to those found in Alzheimer's, Parkinson's and ALS, and can occur as the result of multiple concussions," said Everett J. Lehman, author of the NIOSH study.

The work by NIOSH and UCLA researchers so far has limited practical application. It is aimed at understanding what is happening in the brains of injured athletes and whether those changes share an etiology with neurodegenerative diseases. Through their research, however, may come the means that allow early detection of disease before symptoms occur and possibly the means to prevent those diseases altogether. 

Some of this understanding may come from processes developed more than a century ago by John Snow, M.D., the father of epidemiology. In the mid-1800s, Snow hypothesized that polluted water containing a poison that had the ability “to multiply itself by a kind of growth” in the digestive tract was the underlying cause of cholera. This ran counter to the accepted belief that cholera was due to noxious gases, called miasmas. Snow traced cholera outbreaks in London to polluted wells by meticulously linking victims to where they lived and what they did. Snow died not knowing that the poison he hypothesized was a bacillus, Vibrio cholera, isolated and cultured in 1884 by Robert Koch. 

Today researchers are pursuing tau protein to better understand what is happening in the brains of injured athletes, having visualized its existence with PET in their brains and those of patients with diseases presenting with similar symptoms.

Who knows where it will lead.

Related Content

Artificial Intelligence Predicts Alzheimer's Years Before Diagnosis
News | Neuro Imaging | November 14, 2018
Artificial intelligence (AI) technology improves the ability of brain imaging to predict Alzheimer’s disease, according...
Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018
News | Artificial Intelligence | November 13, 2018
At the 2018 Radiological Society of North America annual meeting (RSNA 2018), Nov. 25-30 in Chicago, Subtle Medical...
University of Missouri Research Reactor First U.S. I-131 Supplier in 30 Years

MURR is the only supplier of I 131 in the United States and the first U.S. supplier since the 1980s. Image courtesy of University of Missouri

News | Radiopharmaceuticals and Tracers | November 13, 2018
The University of Missouri Research Reactor (MURR) recently shipped its first batch of Iodine-131 (I-131), a...
MaxQ AI Receives FDA Clearance for Accipio Ix Intracranial Hemorrhage Platform
Technology | Artificial Intelligence | November 07, 2018
MaxQ AI announced that its Accipio Ix intracranial hemorrhage (ICH) detection software has received 510(k) clearance...
MEDraysintell Projects Increasing Mergers and Acquisitions in Nuclear Medicine
News | Nuclear Imaging | November 07, 2018
With the recent announcement by Novartis to acquire Endocyte , interest from the conventional pharmaceutical industry...
Charles Ananian, M.D.

Charles Ananian, M.D.

Sponsored Content | Case Study | Digital Radiography (DR) | November 07, 2018
Whether it’s a premature baby or a critically ill child, treating little patients is a huge responsibility.
Feature | PET Imaging | November 07, 2018 | By Greg Freiherr
Positron emission tomography (PET) is getting ready to venture outside oncology, cardiology and mainstream neurology....
Podcast | PET Imaging | November 07, 2018
PET is getting ready to venture outside oncology, cardiology and mainstream neurology.
Results of the vertebrae-based analysis (383 vertebrae in 34 patients) for detection of BME.

Results of the vertebrae-based analysis (383 vertebrae in 34 patients) for detection of BME.

Sponsored Content | Case Study | Computed Tomography (CT) | November 06, 2018
The following is a summary of a study published in the